BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 33132768)

  • 1. Hepatoprotective Effects of a Novel Trihoney against Nonalcoholic Fatty Liver Disease: A Comparative Study with Atorvastatin.
    Alfarisi HAH; Ibrahim MB; Mohamed ZBH; Azahari N; Hamdan AHB; Che Mohamad CA
    ScientificWorldJournal; 2020; 2020():4503253. PubMed ID: 33132768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ameliorating effect of probiotic on nonalcoholic fatty liver disease and lipolytic gene expression in rabbits.
    Aziz M; Hemeda SA; Albadrani GM; Fadl SE; Elgendey F
    Sci Rep; 2023 Apr; 13(1):6312. PubMed ID: 37072469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary Supplementation with Hazelnut Oil Reduces Serum Hyperlipidemia and Ameliorates the Progression of Nonalcoholic Fatty Liver Disease in Hamsters Fed a High-Cholesterol Diet.
    Lu JH; Hsia K; Lin CH; Chen CC; Yang HY; Lin MH
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31540081
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatoprotective effects of Shilajit on high fat-diet induced non-alcoholic fatty liver disease (NAFLD) in rats.
    Ghezelbash B; Shahrokhi N; Khaksari M; Ghaderi-Pakdel F; Asadikaram G
    Horm Mol Biol Clin Investig; 2020 Feb; 41(1):. PubMed ID: 32083445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raspberry ketone protects rats fed high-fat diets against nonalcoholic steatohepatitis.
    Wang L; Meng X; Zhang F
    J Med Food; 2012 May; 15(5):495-503. PubMed ID: 22551412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat.
    Jiang W; Guo MH; Hai X
    World J Gastroenterol; 2016 Dec; 22(46):10180-10188. PubMed ID: 28028366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1.
    Jian T; Yu C; Ding X; Chen J; Li J; Zuo Y; Ren B; Lv H; Li W
    J Oleo Sci; 2019 Jun; 68(6):581-589. PubMed ID: 31092797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease.
    Korish AA; Arafah MM
    BMC Complement Altern Med; 2013 Oct; 13():264. PubMed ID: 24119413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from Pleurotus eryngii SI-04.
    Zhang C; Li J; Wang J; Song X; Zhang J; Wu S; Hu C; Gong Z; Jia L
    BMC Complement Altern Med; 2017 Aug; 17(1):403. PubMed ID: 28806986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD).
    Wang Z; Li S; Wang R; Guo L; Xu D; Zhang T; Xu Y; Wang W; Wang M; Gan Z; Wang X
    Mol Med; 2020 Jun; 26(1):54. PubMed ID: 32503411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of Nrf2 and related factors on the progression of nonalcoholic steatohepatitis].
    Cai YQ; Zhang LZ; Wang DJ; Chen FM; Chen ZY; Zhu KY; Li JS; Yan MX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Sep; 30(5):465-70. PubMed ID: 25571645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative markers, nitric oxide and homocysteine alteration in hypercholesterolimic rats: role of atorvastatine and cinnamon.
    Amin KA; Abd El-Twab TM
    Int J Clin Exp Med; 2009 Oct; 2(3):254-65. PubMed ID: 19918318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a novel non‑alcoholic fatty liver disease model using cholesterol‑fed rabbits with reference to the potential role of endoplasmic reticulum stress.
    Wang Y; Zhang P; Su X; Yu Q; Chen Y; Guan H; Liu E; Fan J
    Mol Med Rep; 2018 Sep; 18(3):2898-2904. PubMed ID: 30015906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin.
    Samy W; Hassanian MA
    Arab J Gastroenterol; 2011 Jun; 12(2):80-5. PubMed ID: 21684478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Role of SIRT1/ FGF-21 in Taurine Protection Against Cafeteria Diet-Induced Steatohepatitis in Rats.
    Abd Elwahab AH; Ramadan BK; Schaalan MF; Tolba AM
    Cell Physiol Biochem; 2017; 43(2):644-659. PubMed ID: 28942443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ameliorative effect of statin therapy on oxidative damage in heart tissue of hypercholesterolemic rabbits.
    Sozer V
    Fundam Clin Pharmacol; 2015 Dec; 29(6):558-66. PubMed ID: 26456720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albino mice with the point mutation at the tyrosinase locus show high cholesterol diet-induced NASH susceptibility.
    Kulathunga K; Wakimoto A; Hiraishi Y; Yadav MK; Gentleman K; Warabi E; Sakasai T; Miwa Y; Mizuno S; Takahashi S; Hamada M
    Sci Rep; 2021 Nov; 11(1):21827. PubMed ID: 34750345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague-Dawley Rats.
    Al Zarzour RH; Ahmad M; Asmawi MZ; Kaur G; Saeed MAA; Al-Mansoub MA; Saghir SAM; Usman NS; Al-Dulaimi DW; Yam MF
    Nutrients; 2017 Jul; 9(7):. PubMed ID: 28718838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of tiopronin against high fat diet-induced non-alcoholic steatohepatitis in rats.
    Wang JQ; Zou YH; Huang C; Lu C; Zhang L; Jin Y; Lü XW; Liu LP; Li J
    Acta Pharmacol Sin; 2012 Jun; 33(6):791-7. PubMed ID: 22543705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of dietary flavonoid quercetin against lipemic-oxidative hepatic injury in hypercholesterolemic rats.
    Mariee AD; Abd-Allah GM; El-Beshbishy HA
    Pharm Biol; 2012 Aug; 50(8):1019-25. PubMed ID: 22775419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.